What about Shandong Keyuan Pharmaceutical Co., Ltd.?

Shandong Keyuan Pharmaceutical Co., Ltd. is a high-tech pharmaceutical enterprise jointly funded by Linuo Group, the largest private enterprise in Shandong Province, and Shandong Pharmaceutical Industry Research Institute, mainly engaged in the research and development, production and sales of chemical raw materials. The predecessor of the company is the pilot base of Shandong Institute of Pharmaceutical Industry, which was founded in July 1992. In May 2004, 15 raw materials passed the national GMP certification at one time, and in 2005, four new products passed the national GMP certification. The company believes in the business philosophy of "leading technology, people-oriented", attracting a large number of outstanding talents and creating a strong technological advantage. Obtained API production number 19, including 2 new drugs of 2 categories, more than 4 new drugs of 10, 12 "high-tech products", and was recognized as "high-tech enterprise" by the provincial science and technology department.

The company inherited the industrial strength accumulation, excellent entrepreneurial spirit and solid work style of Linuo Group, and made great innovations in corporate culture, management system, sales channels, scientific research and development, and quality control system. The core competitiveness has been rapidly improved, and three series of products, including gliclazide, metformin hydrochloride, isosorbide mononitrate, nicotinic acid and tinidazole, have gradually formed in the domestic and foreign markets.

Shandong Keyuan Pharmaceutical Co., Ltd. adheres to the rich cultural heritage of Linuo Group, takes "industry serving the country and pursuing Excellence" as its own responsibility, and is committed to building the largest and most professional production base of diabetes, cardiovascular and cerebrovascular diseases and anesthetics in China, making greater contributions to the country and society.

/China /2/ Manufacturer/521420/Main/%E5% B1%B1%E4% B8% 9c% E7% A7% 91 % E6 % BA % 90% E5 % 88% B6 % E8 % 8D % AF % E6 % 9C % 89% E9 % 99% 90% E5 % 85% AC % E5 % 8F % B8 . html